At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GRI GRI BIO INC
Closed 07-22 16:00:00 EDT
1.48
-0.03
-1.99%
盘后1.50
+0.02+1.35%
19:54 EDT
High1.57
Low1.46
Vol23.35K
Open1.51
D1 Closing1.51
Amplitude7.28%
Mkt Cap2.62M
Tradable Cap2.62M
Total Shares1.77M
T/O35.08K
T/O Rate1.32%
Tradable Shares1.77M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Ascencio boosts retail portfolio with €65m Belgian acquisition and capital increase
GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that develops as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in La Jolla, California.